Statement - CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Total revenue	$ 2,964.5	$ 2,530.7	$ 2,417.9
Total cost of revenue	1,451.2	1,225.0	1,208.3
Gross profit	1,513.3	1,305.7	1,209.6
Operating expenses:
Selling, general and administrative	729.4	607.4	561.2
Research and development	294.8	235.9	220.8
Other charges, net	52.2	29.7	14.3
Total operating expenses	1,076.4	873.0	796.3
Operating income	436.9	432.7	413.3
Bargain purchase gain	144.1	0.0	0.0
Interest and other income (expense), net	(36.8)	(18.8)	(19.7)
Income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries	544.2	413.9	393.6
Income tax provision	117.7	116.4	113.0
Equity in income of unconsolidated investees, net of tax	2.0	1.0	0.0
Consolidated net income	428.5	298.5	280.6
Net income attributable to noncontrolling interests in consolidated subsidiaries	1.3	1.9	3.5
Net income attributable to Bruker Corporation	$ 427.2	$ 296.6	$ 277.1
Net income per common share attributable to Bruker Corporation shareholders:
Basic	$ 2.92	$ 2	$ 1.83
Diluted	$ 2.9	$ 1.99	$ 1.81
Weighted average common shares outstanding:
Basic	146.4	148.6	151.4
Diluted	147.2	149.4	152.9
Product
Total revenue	$ 2,457.6	$ 2,109.9	$ 2,017.3
Total cost of revenue	1,165.2	984.0	979.3
Service
Total revenue	493.8	414.6	393.2
Total cost of revenue	285.9	240.8	228.2
Other
Total revenue	13.1	6.2	7.4
Total cost of revenue	$ 0.1	$ 0.2	$ 0.8